| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,389 |
11,615 |
$1.13M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,253 |
4,899 |
$877K |
| 80053 |
Comprehensive metabolic panel |
8,748 |
7,496 |
$184K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,788 |
2,388 |
$121K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,969 |
9,700 |
$116K |
| 71045 |
Radiologic examination, chest; single view |
4,591 |
4,231 |
$113K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,657 |
2,566 |
$104K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,384 |
3,074 |
$92K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
436 |
416 |
$66K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
70 |
67 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
732 |
694 |
$45K |
| 70450 |
Computed tomography, head or brain; without contrast material |
701 |
649 |
$40K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
670 |
642 |
$31K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
419 |
383 |
$30K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
214 |
201 |
$21K |
| 84703 |
|
2,949 |
2,716 |
$17K |
| 81001 |
|
3,368 |
3,116 |
$15K |
| 83690 |
|
2,374 |
2,162 |
$14K |
| 83880 |
|
814 |
724 |
$12K |
| 84484 |
|
2,187 |
1,583 |
$12K |
| 87807 |
|
271 |
259 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
939 |
896 |
$11K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,785 |
1,634 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,362 |
991 |
$9K |
| 84702 |
|
611 |
536 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
287 |
269 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
140 |
136 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,055 |
3,717 |
$5K |
| 87081 |
|
298 |
281 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
658 |
617 |
$3K |
| 80069 |
|
105 |
95 |
$3K |
| G0378 |
Hospital observation service, per hour |
38 |
24 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,028 |
938 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
313 |
275 |
$2K |
| 85610 |
|
940 |
848 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,214 |
1,982 |
$2K |
| 86850 |
|
154 |
144 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
28 |
27 |
$1K |
| 85730 |
|
499 |
462 |
$1K |
| 86769 |
|
47 |
47 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,385 |
1,253 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
269 |
246 |
$960.19 |
| 83735 |
|
339 |
228 |
$929.24 |
| 82550 |
|
317 |
289 |
$922.22 |
| 81003 |
|
524 |
492 |
$907.31 |
| 80076 |
|
28 |
25 |
$708.98 |
| 86901 |
|
437 |
360 |
$690.96 |
| 86900 |
|
437 |
360 |
$690.88 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,123 |
835 |
$558.89 |
| 83605 |
|
64 |
51 |
$327.95 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,166 |
1,859 |
$234.82 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
216 |
201 |
$124.73 |
| 85379 |
|
40 |
39 |
$120.75 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
39 |
36 |
$117.72 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
38 |
36 |
$115.27 |
| 84145 |
|
14 |
13 |
$106.14 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
334 |
292 |
$59.78 |
| 86140 |
|
14 |
13 |
$33.18 |
| 96376 |
|
26 |
24 |
$8.56 |
| 82962 |
|
1,790 |
501 |
$4.92 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13 |
12 |
$0.75 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
691 |
316 |
$0.27 |
| J3490 |
Unclassified drugs |
65 |
51 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
67 |
63 |
$0.00 |